Mechanistically, MLT ameliorates lysosomal dysfunction in renal tubular epithelial cells by activating TFEB-mediated modulation of the miR-205-LRP-1 signaling axis, thereby attenuating renal injury in DKD. Here, TFEB is linked to diabetic kidney disease.